Literature DB >> 9850848

Role of interleukin-7 in T-cell development from hematopoietic stem cells.

K Akashi1, M Kondo, I L Weissman.   

Abstract

All lymphocytes are derived from hematopoietic stem cells (HSC). The interleukin-7 receptor (IL-7R) transduces non-redundant signals for both T and B-cell development from HSC. The upregulation of the IL-7R occurs at the stage of the clonogenic common lymphoid progenitor, a recently identified population that can give rise to all lymphoid lineages (T, B and natural killer cells) at a single cell level. The IL-7R plays a critical role in the rearrangement of immunoglobulin heavy chain genes required for B-cell development. IL-7R expression is critically regulated in developing thymocytes; thymocytes that fail the positive selection process downregulate the IL-7R, but those undergoing positive selection upregulate or maintain IL-7R expression. Recent data indicate that IL-7 signaling enhances the survival of developing thymocytes and mature T cells, presumably by its upregulating Bcl-2. Detailed analysis of the signaling cascades activated by the IL-7R may help to reveal the differential roles of IL-7 signaling in T and B-cell development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9850848     DOI: 10.1111/j.1600-065x.1998.tb01226.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  20 in total

Review 1.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

Review 2.  Lineage promiscuous expression of transcription factors in normal hematopoiesis.

Authors:  Toshihiro Miyamoto; Koichi Akashi
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

Review 3.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

4.  Constitutively active Stat5b in CD4+ T cells inhibits graft-versus-host disease lethality associated with increased regulatory T-cell potency and decreased T effector cell responses.

Authors:  Christine Vogtenhuber; Christoph Bucher; Steven L Highfill; Lisa K Koch; Emily Goren; Angela Panoskaltsis-Mortari; Patricia A Taylor; Michael A Farrar; Bruce R Blazar
Journal:  Blood       Date:  2010-05-04       Impact factor: 22.113

5.  Store-Operated Ca2+ Entry Controls Clonal Expansion of T Cells through Metabolic Reprogramming.

Authors:  Martin Vaeth; Mate Maus; Stefan Klein-Hessling; Elizaveta Freinkman; Jun Yang; Miriam Eckstein; Scott Cameron; Stuart E Turvey; Edgar Serfling; Friederike Berberich-Siebelt; Richard Possemato; Stefan Feske
Journal:  Immunity       Date:  2017-10-11       Impact factor: 31.745

6.  Stepwise activation of the immunoglobulin mu heavy chain gene locus.

Authors:  D Chowdhury; R Sen
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

7.  IL7Rα contributes to experimental autoimmune encephalomyelitis through altered T cell responses and nonhematopoietic cell lineages.

Authors:  Jessica J Ashbaugh; Roberta Brambilla; Shaffiat A Karmally; Cecilia Cabello; Thomas R Malek; John R Bethea
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

Review 8.  The discovery of novel experimental therapies for inflammatory arthritis.

Authors:  Charles J Malemud
Journal:  Mediators Inflamm       Date:  2010-03-18       Impact factor: 4.711

9.  Synergistic effects of interleukin-7 and pre-T cell receptor signaling in human T cell development.

Authors:  Ekta S Patel; Lung-Ji Chang
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

10.  Essential requirement for c-kit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2.

Authors:  H R Rodewald; C Waskow; C Haller
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.